Search - tctmd.com

Displaying 81 - 100 of 155

Sort: Relevancy | Date

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

News Daily News

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

January 31, 2019

TCTMD’s Top 10 Most Popular Stories for October 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

October 31, 2018

A Look Back at TCT 2018: What I Took Away From the Meeting

News Opinion Fellow Talk

A Look Back at TCT 2018: What I Took Away From the Meeting

Yashasvi Chugh, MD

October 23, 2018

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

October 02, 2018

CTO PCI Patients With CKD Have More Acute Kidney Injury but Not Dialysis or TLF Over 2 Years

News Conference News TCT 2018

CTO PCI Patients With CKD Have More Acute Kidney Injury but Not Dialysis or TLF Over 2 Years

Yael L. Maxwell

September 23, 2018

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

August 09, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

ICD Benefit Questioned in Patients With Chronic Kidney Disease

News Daily News

ICD Benefit Questioned in Patients With Chronic Kidney Disease

February 09, 2018

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

News Daily News

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Yael L. Maxwell

November 28, 2017

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

October 16, 2017

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

October 10, 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

September 11, 2017

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

Kidney Transplant Recipients Fare About as Well as Other Patients With STEMI

January 13, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

January 06, 2017

News Conference News AHA 2016

误诊 NOAC 在日常实践中很常见，并对中风和出血有影响

November 21, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.